Applied BioCode Corporation (TPE:6598)

Applied BioCode Revenue

Applied BioCode had revenue of 217.12M TWD in the quarter ending March 31, 2026, with 80.95% growth. This brings the company's revenue in the last twelve months to 572.33M, up 50.00% year-over-year. In the year 2025, Applied BioCode had annual revenue of 475.20M with 38.52% growth.

• Revenue (ttm): 572.33M
• Revenue Growth: +50.00%
• P/S Ratio: 4.45
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	475.20M	132.13M	38.52%
Dec 31, 2024	343.07M	-52.10M	-13.18%
Dec 31, 2023	395.17M	4.87M	1.25%
Dec 31, 2022	390.30M	70.34M	21.98%
Dec 31, 2021	319.96M	20.95M	7.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error